赤天化(600227) - 2025 Q2 - 季度业绩预告

Current Period Performance Forecast The company anticipates continued losses in H1 2025, with net profit attributable to shareholders estimated between RMB -35 million and -52 million, and non-recurring net profit between RMB -36 million and -53 million 2025 Semi-Annual Performance Forecast | Performance Indicator (2025 Semi-Annual Forecast) | Amount Range (RMB) | | :------------------------------------------------ | :------------------------------- | | Net Profit Attributable to Parent Company Shareholders | -35 Million RMB to -52 Million RMB | | Net Profit Attributable to Parent Company Shareholders After Deducting Non-Recurring Gains and Losses | -36 Million RMB to -53 Million RMB | - The company explicitly states that the performance forecast data for this period has not been audited by a certified public accountant[3] Operating Performance and Financial Status for the Same Period Last Year In H1 2024, the company reported a net loss attributable to parent company shareholders of RMB 36.743 million and a non-recurring net loss of RMB 50.1754 million, with earnings per share at RMB -0.0217 2024 Semi-Annual Operating Performance | Performance Indicator (2024 Semi-Annual) | Amount/Value (RMB) | | :--------------------------------------- | :----------------- | | Total Profit | -36.3042 Million RMB | | Net Profit Attributable to Parent Company Shareholders | -36.7430 Million RMB | | Net Profit Attributable to Parent Company Shareholders After Deducting Non-Recurring Gains and Losses | -50.1754 Million RMB | | Earnings Per Share | -0.0217 RMB | Primary Reasons for Current Period's Estimated Loss The estimated loss primarily stems from core business challenges, including high fixed costs in hospital operations during market cultivation and high production costs in coal mining due to limited output and declining market prices, partially offset by positive non-operating gains Impact of Core Business Operations Core business losses are driven by hospital operations facing high fixed costs despite revenue growth, and coal mining experiencing high production costs due to limited output and declining market prices - Hospital business remains in its market and reputation cultivation phase, with increasing operating revenue insufficient to cover high fixed costs, including labor, depreciation, amortization, and financial expenses, leading to continuous losses[6] - Coal mining business, despite increased production and sales, faces high production costs due to most mining faces being in the excavation layout stage, resulting in low overall raw coal output; declining coal market prices in 2025 further negatively impacted the business, leading to losses[6] Impact of Non-Operating Gains and Losses Non-operating gains and losses positively impacted net profit by approximately RMB 1.1 million in H1 2025, primarily from government subsidies recognized in current period profit or loss - Non-operating gains and losses had a positive impact of approximately RMB 1.1 million on net profit in the first half of 2025, primarily from government subsidies recognized in current period profit or loss[6] Risk Warning The company emphasizes that this performance forecast is a preliminary, unaudited financial department calculation, with no significant uncertainties identified that would impact its accuracy - The company states that this performance forecast is a preliminary calculation by the finance department and has not been audited by a certified public accountant[7] Other Explanatory Matters Investors are reminded that the disclosed data is preliminary, and final accurate financial data will be based on the officially released 2025 semi-annual report, with investment risks noted - The final accurate financial data will be based on the company's officially disclosed 2025 semi-annual report; investors are advised to be aware of investment risks[8]